Viewing Study NCT06090474



Ignite Creation Date: 2024-05-06 @ 7:41 PM
Last Modification Date: 2024-10-26 @ 3:11 PM
Study NCT ID: NCT06090474
Status: COMPLETED
Last Update Posted: 2023-10-24
First Post: 2023-10-06

Brief Title: Multiple Dose Study to Evaluate Drug-drug Interactions Safety and Tolerability of NDC-002 in Healthy Volunteers
Sponsor: Dr Noah Biotech Inc
Organization: Dr Noah Biotech Inc

Study Overview

Official Title: An Open-label One-sequence Three-period Multiple-dose Study to Evaluate Drug-drug Interactions Safety and Tolerability Between NDC-002ANDC-002B and NDC-002C in Healthy Volunteers
Status: COMPLETED
Status Verified Date: 2023-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: An Open-label One-sequence Three-period Multiple-dose Study to Evaluate Drug-drug Interactions Safety and Tolerability between NDC-002ANDC-002B and NDC-002C in Healthy Volunteers
Detailed Description: This is an Open-label One-sequence Three-period Multiple-dose Study and the goal of this clinical trial is to evaluate in health Volunteers

The main questions it aims to answer are

Drug-drug Interactions
Safety
Tolerability

The study consisted of Three-period Period 1 which repeated administration of NDC-002C for 7 days and Period 2 which repeated administration of NDC-002A for 7 days followed by administration of NDC-002B for 8 days and Period 3 which repeated concomitant administration of NDC-002B and NDC-002C for 7 days

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None